Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of carfilzomib

A carfilzomib and intermediate technology, applied in the field of medicinal chemistry, can solve the problems of less manganese complex catalysts, less side reactions, limited application and the like, and achieve the effects of low cost, simple operation and simple reaction conditions

Active Publication Date: 2020-12-01
CHANGZHOU HANSOH PHARM CO LTD +2
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] This route uses hydrogen peroxide as the oxidant, has fewer side reactions, and the yield is as high as 96%. At the same time, a manganese complex catalyst is used for asymmetric epoxidation, and the chiral selectivity dr value is 7:1 (Formula I: Formula II) , to reduce the pressure of subsequent purification, but commercially available manganese complex catalysts are less and expensive, which limits the application of this route in industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of carfilzomib
  • A kind of preparation method of carfilzomib
  • A kind of preparation method of carfilzomib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033]Add the compound of formula III (25.5g, 100 mmol), (2S)-2-[diphenyl[(trimethylsilyl ester)oxy]methyl]-pyrrolidine (3.7g, 10 mmol) to the reaction flask , Toluene (250 mL),N-Methylpyrrolidone (500 mL), stir well, cool to -3°C, slowly add hydrogen peroxide (34.0g, 30% aqueous solution, 300 mmol) dropwise at -5 to 0°C. After the dripping is completed, the reaction is kept for 4 hours.

[0034]TLC detection, after the reaction is complete, add sodium thiosulfate solution to quench (200 mL), add n-hexane (400 mL) for extraction and liquid separation, and then wash the organic phase with purified water (200 mL) and saturated brine (200 mL) , Dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure to obtain an oily substance, and obtain a solid after recrystallization from n-hexane. The molar yield is 83%, the purity is 99.3%, and the chiral selectivity of the compound of formula I: the compound of formula II is 15:1.

[0035]1H NMR (400 MHz, CDCl3)δ 0.9 (d...

Embodiment 2

[0038]Add the compound of formula III (25.5g, 100 mmol), (2S)-2-[diphenyl[(triethylsilyl ester)oxy]methyl]-pyrrolidine (3.7g, 10 mmol) into the reaction flask , Toluene (250 mL),N-Methylpyrrolidone (500 mL), stir well, cool to -3°C, slowly add hydrogen peroxide (34.0g, 30% aqueous solution, 300 mmol) dropwise at -5 to 0°C. After the dropwise addition was completed, the reaction was kept for 4 hours.

[0039]TLC detection, after the reaction is complete, add sodium thiosulfate solution to quench (200 mL), add n-hexane (400 mL) for extraction and liquid separation, and then wash the organic phase with purified water (200 mL) and saturated brine (200 mL) , Dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure to obtain an oily substance, and obtain a solid after recrystallization from n-hexane. The molar yield is 84%, the purity is 99.5%, and the chiral selectivity of the compound of formula I: the compound of formula II is 17:1.

[0040]The hydrogen spectru...

Embodiment 3

[0042]Add the compound of formula III (25.5g, 100 mmol), (2S)-2-[diphenyl[(triethylsilyl ester)oxy]methyl]-pyrrolidine (0.7g, 2 mmol) to the reaction flask , Toluene (250 mL),N -Methylpyrrolidone (500 mL), stir well, cool to -3°C, slowly add hydrogen peroxide (34.0g, 30% aqueous solution, 300 mmol) dropwise at -5 to 0°C. After the dropwise addition was completed, the reaction was kept for 4 hours.

[0043]TLC detection, after the reaction is complete, add sodium thiosulfate solution to quench (200 mL), add n-hexane (400 mL) for extraction and liquid separation, and then wash the organic phase with purified water (200 mL) and saturated brine (200 mL) , Dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure to obtain an oily substance, and obtain a solid after recrystallization from n-hexane. The molar yield is 65%, the purity is 89%, and the chiral selectivity of the compound of formula I: the compound of formula II is 4.4:1.

[0044]The hydrogen spectrum a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of carfilzomib, which comprises the following steps of: by using a compound represented by a formula I as an intermediate, carrying out deprotection, andreacting with a compound represented by a formula IV to prepare carfilzomib. The preparation method of the compound shown in the formula I comprises the following steps of: taking hydrogen peroxide asan oxidizing agent, and preparing a carfilzomib intermediate, namely the compound shown in the formula I, through selective epoxidation of a chiral organic catalyst. The preparation method disclosedby the invention is simple in reaction condition, simple and convenient to operate, good in asymmetric selectivity, good in yield, high in purity and suitable for industrial production.

Description

Technical field[0001]The invention relates to the field of medicinal chemistry, in particular to a preparation method of carfilzomib.Background technique[0002]Carfilzomib, chemical name (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-Methyloxirane-2-yl)-1-pentanoyl-2-yl-carbamoyl)-2-phenylethyl)-2-((S)-2-(2-Morpholine acetylamino)-4-phenylbutyrylamino)-4-methylpentanamide is a protease inhibitor developed by Onyx Pharmaceuticals Inc, USA, for the treatment of multiple myeloma . It was approved by the US FDA on July 20, 2012 for the treatment of multiple myeloma patients who have failed to treat with other drugs. among them,[(S)-4-methyl-1-[(R)-2-Methyloxirane-2-yl]-1-pentanone-2-yl]carbamate is a key intermediate for the preparation of carfilzomib, and its structure is shown in formula I, The compound of formula II is its optical isomer.[0003]For the synthesis of this key intermediate, the following methods have been reported:[0004]Bioorg. Med. Chem. Lett. 1999, 9, 2283 reported for the first ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D303/36C07K7/06C07K1/06
CPCC07D303/36C07K7/06
Inventor 高彪张丰盈葛广存何劼孙运栋
Owner CHANGZHOU HANSOH PHARM CO LTD